Stoke Therapeutics Inc buy Chardan Capital
Start price
19.02.25
/
50%
€8.95
Target price
19.02.26
€23.00
Performance (%)
221.79%
End price
20.02.26
€28.80
Summary
This prediction ended on 20.02.26 with a price of €28.80. With a performance of 221.79% the BUY prediction by Chardan_Capital was a big success. Chardan_Capital has a follow-up prediction for Stoke Therapeutics Inc where he still thinks Stoke Therapeutics Inc is a Buy. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Stoke Therapeutics Inc | -1.351% | -1.351% | 281.699% |
| iShares Core DAX® | -1,10 % | -6,08 % | 3,20 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % | 20,24 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % | 27,55 % |
| iShares S&P 500 | -0,06 % | 0,88 % | 14,89 % |
Comments by Chardan_Capital for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $24.00 price target on the stock.
Ratings data for STOK provided by MarketBeat
In the thread Trading Stoke Therapeutics Inc
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten
Current prediction by Chardan_Capital for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€13.80
13.08.25
13.08.25
€20.55
13.08.26
13.08.26
111.59%
13.03.26
13.03.26
Stopped prediction by Chardan_Capital for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€25.80
05.01.26
05.01.26
€29.93
05.01.27
05.01.27
13.18%
13.03.26
13.03.26
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€10.70
20.12.24
20.12.24
€23.06
20.12.25
20.12.25
152.34%
21.12.25
21.12.25